Kentucky & Southern Indiana Chapter

Browse chapters by location

The Word:


Professional Education Programs

The Leukemia & Lymphoma Society (LLS) sponsors a number of free community-based professional education programs for healthcare professionals, particularly for oncology nurses and social workers. Patients, their families and caregivers are also invited to attend.

These programs are led by local doctors and other healthcare professionals and offer continuing education credits for nurses and social workers.

Cancer Treatment: How to Make Informed Choices about Standard Care and Clinical Trials
Topics Covered:
- List steps patients can take to make informed treatment decisions                       - Advise patients about the benefits and risks of standard treatment and treatment in a clinical trial
- Describe how new cancer treatments are developed and approved                         - Sort out the myths from the facts about clinical trials
- Explain how to search for clinical trial listings for blood cancers                            - Identify resources offered by The Leukemia & Lymphoma Society

Staying Connected: Facilitating the Learning Experience During and After Cancer Treatment
Topics covered:
- Identify cancers that affect children, adolescents and young adults (AYAs)
- Identify side efects, long-term and late efects of childhood/AYA cancer treatment
- Describe challenges for survivors throughout their education 
- Explain laws that protect childhood/AYA cancer survivor's rights
- Develop strategies to help meet the student's short and long-term education needs - Access resources that support schools and families, including those from The Leukemia & Lymphoma Society

Myeloma Update: Diagnosis, Treatment and Side Effects Management
2.0 CE contact hours
2.0 CE (1.75 clinical and 0.25 social work ethics) clock hours
Goal: To educate oncology nurses and social workers on the current and emerging therapies in the treatment of myeloma.

By the end of this program, you should be able to:
- describe diagnosis and current treatment options for individuals living with myeloma
- describe side effects and symptom management for myeloma
- identify emerging therapies under study for myeloma
- explain the role of stem cell transplantation in myeloma treatment
- apply strategies to enhance quality of life for individuals living with myeloma
Supported by grants from Celgene Corporation and Millennium Pharmaceuticals, Inc.

Welcome Back: Working Together to Support the Cancer Survivor at School
3.0 CE contact hours
3.0 CE clinical clock hours
Goal: To educate school personnel and parents on the cognitive and late effects of treatment of childhood, adolescent and young adult cancer to improve the transition of cancer survivors from clinic to classroom.

By the end of this program, you should be able to:
- describe common cancers and treatments affecting children, adolescents and young adults
- identify challenges for survivors as they return to school, continue their education and progress through young adulthood
- explain laws that protect the rights of childhood, adolescent and young adult cancer survivors
- implement strategies to help meet students' short- and long-term educational needs
- access resources that support schools and families, including those from LLS

Continuing Education
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society's under provider number CEP 5832 to award 2.0 continuing education contact hours through the California Board of Registered Nursing.

Social Workers
The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education Program (ACE). Approval Period: 12/2008-12/2011. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 2.0 CE (1.75 clinical and .25 social work ethics) clock hours.

CLL: Update on Treatment and Side Effects Management

Registration coming soon.

Emerging Immunotherapies for Hematologic Malignancies: Improving Patient Outcomes by Harnessing the Immune System

This activity is for researchers, hematologists, oncologists and other healthcare professionals.

From Omics to Clinics: Using New Technologies to Advance Diagnosis and Treatment of Hematologic Malignancies

This activity is designed for hematologists, oncologists, and other healthcare professionals.

In addition to our local programs, we sponsor a range of free live and archived online continuing education programs, conferences, meetings and events. For a complete list of our programs, see Continuing Medical Education and Continuing Education Units.

last updated on Monday, February 25, 2013